Obvez Labs Profile
Key Indicators
- Authorised Capital ₹ 3.60 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.60 Cr
as on 17-07-2024
- Company Age 7 Year, 16 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.28 Cr
as on 17-07-2024
- Revenue 5.46%
(FY 2023)
- Profit 111.70%
(FY 2023)
- Ebitda 1.89%
(FY 2023)
- Net Worth 5.47%
(FY 2023)
- Total Assets 8.64%
(FY 2023)
About Obvez Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.60 Cr and a paid-up capital of Rs 3.60 Cr.
The company currently has active open charges totaling ₹6.28 Cr.
Lakshminarayna Marepalli, Srinivas Jagarlapudi, Lakshmi Addeapalli, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999TG2017PTC120998
- Company No.
120998
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Obvez Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshminarayna Marepalli  | Managing Director | 03-Feb-2018 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivas Jagarlapudi | Director | 05-Dec-2017 | Current |
| Lakshmi Addeapalli | Director | 22-Jun-2018 | Current |
| Venkata Chunduru | Director | 28-Sep-2018 | Current |
| Nageswara Kalangi | Director | 21-Jul-2023 | Current |
Financial Performance of Obvez Labs.
Obvez Labs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.46% increase. The company also saw a substantial improvement in profitability, with a 111.7% increase in profit. The company's net worth moved up by a moderate rise of 5.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Obvez Labs?
In 2023, Obvez Labs had a promoter holding of 63.13% and a public holding of 36.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Dec 2018 | ₹6.28 Cr | Open |
How Many Employees Work at Obvez Labs?
Obvez Labs has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Obvez Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Obvez Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
